Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.055 | 0.4 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |